Birgit Korioth-Schmitz
Overview
Explore the profile of Birgit Korioth-Schmitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
887
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chouman K, Korioth-Schmitz B, Sack M, Schmitz J, Pham A, Fischer R, et al.
Eur Cytokine Netw
. 2018 Aug;
29(2):59-72.
PMID: 30148452
Interleukin-6 (IL-6) expression and secretion, induced by inflammatory processes, stimulate the acute phase response cascade. The overexpression of IL-6 contributes to a variety of inflammatory diseases, e.g. rheumatoid arthritis, Castleman's...
2.
Korioth-Schmitz B, Perley C, Sixsmith J, Click E, Lee S, Letvin N, et al.
Vaccine
. 2015 Jul;
33(42):5715-5722.
PMID: 26192357
Background: A recombinant Mycobacterium bovis BCG (rBCG) vector expressing HIV transgenes is an attractive candidate as a dual vaccine against HIV and TB. However, pre-existing immune responses to mycobacteria may...
3.
Gombos R, Kolodkin-Gal D, Eslamizar L, Owuor J, Mazzola E, Gonzalez A, et al.
J Virol
. 2015 May;
89(15):7813-28.
PMID: 25995259
Unlabelled: To date, most therapeutic and vaccine candidates for human immunodeficiency virus type 1 (HIV-1) are evaluated preclinically for efficacy against cell-free viral challenges. However, cell-associated HIV-1 is suggested to...
4.
Panas M, Sixsmith J, White K, Korioth-Schmitz B, Shields S, Moy B, et al.
Infect Immun
. 2014 Oct;
82(12):5317-26.
PMID: 25287928
Mycobacteria, the etiological agents of tuberculosis and leprosy, have coevolved with mammals for millions of years and have numerous ways of suppressing their host's immune response. It has been suggested...
5.
Venkataswamy M, Ng T, Kharkwal S, Carreno L, Johnson A, Kunnath-Velayudhan S, et al.
PLoS One
. 2014 Sep;
9(9):e108383.
PMID: 25255287
Recombinant Mycobacterium bovis bacillus Calmette-Guèrin (rBCG) has been explored as a vector for vaccines against HIV because of its ability to induce long lasting humoral and cell mediated immune responses....
6.
Sixsmith J, Panas M, Lee S, Gillard G, White K, Lifton M, et al.
Clin Vaccine Immunol
. 2014 Aug;
21(10):1385-95.
PMID: 25080550
Live attenuated nonpathogenic Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediates long-lasting immune responses, has been safely administered as a tuberculosis vaccine to billions of humans, and is affordable to produce as...
7.
McGee K, Haim H, Korioth-Schmitz B, Espy N, Javanbakht H, Letvin N, et al.
J Virol
. 2013 Oct;
88(1):21-40.
PMID: 24131720
Envelope glycoprotein (Env) reactivity (ER) describes the propensity of human immunodeficiency virus type 1 (HIV-1) Env to change conformation from the metastable unliganded state in response to the binding of...
8.
Kolodkin-Gal D, Hulot S, Korioth-Schmitz B, Gombos R, Zheng Y, Owuor J, et al.
J Virol
. 2013 Oct;
87(24):13589-97.
PMID: 24109227
Effective strategies are needed to block mucosal transmission of human immunodeficiency virus type 1 (HIV-1). Here, we address a crucial question in HIV-1 pathogenesis: whether infected donor mononuclear cells or...
9.
Schmitz J, Korioth-Schmitz B
Curr Opin HIV AIDS
. 2013 Apr;
8(4):273-9.
PMID: 23615117
Purpose Of Review: Soon after the discovery of HIV-infected humans, rhesus macaques in a colony at the New England Primate Research Center showed similar signs of a progressive immune suppression....
10.
Zahn R, Rett M, Li M, Tang H, Korioth-Schmitz B, Balachandran H, et al.
Blood
. 2010 Feb;
115(15):3070-8.
PMID: 20147699
One of the most puzzling observations in HIV research is the lack of pathogenicity in most nonhuman primate species that are natural hosts of simian immunodeficiency virus (SIV) infection. Despite...